Marshall Wace North America’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-34,383	Closed	-$1.04M	–	1520
2020 Q3	$1.04M	Buy	+34,383	New	+$1.04M	0.01%	795